Unbalanced chromosomal abnormalities might lead to different genetic disorders as well as cancer. Array CGH can be used to identify imbalances in an entire genome with higher resolution than traditional microscopic methods. The above aberrations could be correlated with genome regions that might be useful in identification of the primary origin of tumor.
Unbalanced chromosomal abnormalities might lead to different genetic disorders as well as cancer. Array CGH can be used to identify imbalances in an entire genome with higher resolution than traditional microscopic methods. The above aberrations could be correlated with genome regions that might be useful in identification of the primary origin of tumor.
USAGE OF EACH TEST: As a detection of early relapse and as follow-up tool
USEFUL INFO: This test requires 7 to 10 ml of whole (peripheral) blood in a provided 10ml volume vial tube with an immobilized liquid. For tissue samples the minimum quantity of 400mg is required in a provided vial.
CONSIDER THAT the Follow-up tests are not intended to be used as methods of confirming the establishment of cancer disease primarily (diagnostic purposes). Follow-up tests are intended to be used to control the risk of relapse and monitor patient’s status during and after treatment.
RGCC provides the necessary sampling kit with detailed instructions for sampling – Collection and logistics upon request
SUPPORT AND TRAINING: RGCC provides on call and online support on issues of interpretation and Procedures of the test. Additionally, we provide regular training course for clinicians in order to familiarize them with the tests (Seminars & Webinars).
One transportation container contains:
Please ensure that the medical form is completed, signed by a doctor and patient and enclosed to the package.